Úvod: Zdokonalení prevence a léčby ischemické choroby srdeční i zvýšení dostupnosti koronárních jednotek představují významná opatření pro snížení incidence akutních koronárních syndromů (AKS). Pro optimální algoritmus hospitalizace a léčby pacientů s AKS je naprosto nezbytné vytvoření systému akutní koronární péče. Cíl: Cílem naší studie bylo stanovit roční incidenci AKS i kvalitu akutní koronární péče v Litvě. ABSTRACT Introduction: Improvement in coronary heart disease prevention and treatment, as well as availability of coronary care facilities, are important measures for reduction of acute coronary syndrome (ACS) incidence. Centralized acute coronary care system is crucial to provide optimal hospitalization and management algorithm for ACS patients.
Introduction
Continuous physician education, development of clinical guidelines and recommendations, and its implementation in practice, availability of diagnostic coronary angiography and coronary intervention are measures that are crucial in reduction of acute coronary syndrome (ACS) morbidity. Moreover, centralized emergency medical services (EMS) are vital in order to promote optimal algorithm of hospitalization or the transfer to specialized hospitals to provide best possible care for patients with ACS. ACS registry, covering the whole country, represents both consequences of primary and secondary prevention by decreasing incidence of ACS as well as serves as a measure for quality of care in patients hospitalized with ACS.
The new member states of the European Union have high cardiovascular disease rates, which is in marked contrast to the most economically stable European countries where declines in cardiovascular mortality rates have been experienced over last 30 years [1] . Coronary heart disease is the leading cause of death in Latvia [2] . ACS is the most common reason for cardiac hospitalization tied with high mortality risk and requiring advanced care [3] .
Early coronary angiography and revascularization is a cornerstone in contemporary management of ACS, however, improvement of regionalized systems is of no less importance [4] [5] [6] [7] . In patients with ST-segment elevation myocardial infarction (STEMI) primary percutaneous coronary intervention (P-PCI) in a time saving manner is the preferred strategy. Thus empowering EMS and implementation of regional guidelines were the fi rst steps in forming an effective STEMI regional network providing majority of patients with P-PCI and others with fi brinolysis (FL) and facilitated PCI. Additionally early invasive strategy in non-ST-elevation ACS (NSTE-ACS) patients reduces refractory ischemia and improves survival in intermediate and high risk NSTE-ACS patients [5, [8] [9] [10] [11] [12] [13] [14] .
Assessment of quality has become an integral part of care, usually by the evaluation of implementation of clinical guidelines in real life practice. Thus, to analyze acute coronary care quality in Latvia, the ongoing national registry of ACS was introduced in the year 2005. The aim of this report was to analyze annual incidence of ACS and quality of care in ACS patients during the time period of 5 years from 2005 to 2010 in Latvia.
Methods
The Latvian Registry of Acute Coronary Syndromes is an ongoing, prospective, multi-center, observational registry designed to examine current epidemiology, in-hospital management and the outcome of patients with ACS in Latvia. A total of 34 hospitals participated in the registry during study period from 1st of January 2005 to 31st of December 2010. To minimize selection bias all consecutive patients with a suspected diagnosis of acute coronary syndrome were included, regardless of the treatment strategy, or outcome. Data concerning baseline demographic and clinical characteristics, relevant laboratory results, pharmacotherapy during hospital stay, and adverse cardiovascular outcomes were recorded on a standardized electronic [15, 16] . For the purpose of the present analysis patients were classifi ed as NSTE-ACS and STEMI. The occurrence of other ischemic or bleeding events was not analyzed. We analyzed: adherence to therapies recommended by guidelines, early interventional strategy, coronary risk factors, patient history data and in-hospital mortality. Hypercholesterolemia was defi ned as total blood cholesterol above 4.5 mmol/l, and arterial hypertension was defi ned as blood pressure 140/90 mmHg or above without medications or the use of antihypertensive agents in history.
Reperfusion strategy was documented in STEMI patients. STEMI patients eligible for reperfusion therapy were defi ned as patients hospitalized within 12 h from symptom onset. Reperfusion strategy, P-PCI or fi brinolysis (FT) was analyzed in this patient subgroup.
The data of Central Statistical Bureau Database of Latvia were used for the calculation of annual incidence of STEMI and NSTE-ACS per million population. This was calculated for each year using number of total population for each year given by Central Statistical Bureau Database of Latvia.
Statistical analyses
Statistical analyses were performed with SPSS software (version 17.0, Chicago, Illinois, USA). Continuous values are expressed as mean ± SD. Categorical variables are presented as percentages. Categorical variables were compared with Chi-square test and continuous variables with ANOVA. P values under 0.05 were considered as statistically signifi cant.
Results
Since the year 2005 the total number of ACS patients, both STEMI and NSTE-ACS, hospitalized across Latvia as assessed by current registry decreased (Tables 1 and 2 ). Number of STEMI and NSTE-ACS calculated per million population decreased over years ( Fig. 1 ). More prominent decrease was observed among NSTE-ACS patients. To- Absolute numbers of transferred patients from community hospitals to PCI centers increased over years (Fig. 3) .
Discussion
The Evaluation of intra-hospital acute coronary care confi rmed better adherence to evidence-based guidelines. Not only more frequent administration of recommended drugs but also more common use of diagnostic coronary angiograms followed by PCI was observed. Increase in the use of interventional strategy in the management of tal number of patients hospitalized with NSTE-ACS decreased almost two fold based on registry data. Early interventional strategy and better adherence to guidelines recommended therapies improved in NSTE-ACS patients over years (Table 1) . Reduction in intra-hospital mortality was observed in year 2010 in NSTE-ACS patients ( Table 1) .
The use of P-PCI in Latvia signifi cantly increased from 7.9% in 2005 to 57.0% in 2010 along with use of antiplatelet therapy (Tables 2 and 3 (Fig. 2) . However, only slight decrease of intra-hospital mortality in STEMI patients over years was observed. Intra-hospital mortality rates in STEMI patients without any reperfusion remained very high (Table 4) . both NSTE-ACS and STEMI was the result of not only physician education and availability of interventional centers, but also restructuring and centralization of EMS in Latvia. Admission to higher-volume hospitals was associated with a reduction in mortality for acute myocardial infarction according to literature [17] , thus number of small capacity community hospitals was restructured to serve as ambulatory clinics and total number of hospitals providing acute coronary care was reduced from 35 in year 2005 to 18 in year 2010. Reduction of low capacity hospitals in acute coronary care network provides possibility for ACS patients to be hospitalized to higher-volume centers, thus expecting better quality of care and prognosis.
Majority of patients with ACS arrive at the hospital via EMS ambulance in Latvia, thus EMS plays a crucial role in the distribution of ACS patients among hospitals. EMS was restructured and served as a centralized system ensuring hospitalization of ACS patients to tertiary centers only since 2009-2010. STEMI network algorithms were adapted from European Society of Cardiology recommendations and adjusted for local situation, published in local guidelines and implemented in real life practice [4] [5] [6] . Thus, more STEMI patients were routed directly to interventional centers or transferred on the next day after FL if more than 2-hour delay from the fi rst medical contact to balloon was expected. As a result signifi cant increase in use of P-PCI from 7.9% in 2005 to 57.0% in 2010 and decrease in STEMI patients without any reperfusion was observed (Table 3 , Fig. 2) . P-PCI is preferable and it is the leading reperfusion strategy for STEMI in most European countries [18] , however, in the "real world" choice of a management strategy is often governed by the facilities available in the hospital where patients initially present. Only four hospitals in Latvia (two hospitals in Riga) have PCI facilities and 24-hour/7-day interventional access is available only in Riga (since 2007 one hospital and since February 2010 two hospitals).
Positive associations between interventional strategy and improved outcomes in patients with ACS argue for the routing of those patients from community hospitals to hospitals with access to catheterization laboratory [18] [19] [20] [21] [22] [23] [24] . Partly, problems were settled with better organization of networks among the EMS and P-PCI hospitals. This resulted in signifi cant increase in absolute numbers of transferred patients from community hospitals to PCI centers over years (Fig. 2) . Those patients were routed to Latvian Centre of Cardiology mainly for coronary intervention. 74.5% (n = 190) from transferred NSTE-ACS and 90.7% (n = 233) from transferred STEMI patients underwent interventional treatment at index hospitalization in year 2010. Coronary angiography was performed in 91.0% (n = 232) transferred NSTE-ACS and in 95.7% (n = 246) transferred STEMI patients in 2010.
Despite better adherence to guidelines recommended therapies only slight decrease in intra-hospital mortality was achieved. Very high intra-hospital death rates were observed in patient subgroup without any reperfusion (Table 4) contributing to high total intra-hospital mortality rates in STEMI patients. STEMI patients in cardiogenic shock had high in-hospital mortality, especially those without reperfusion ranging from 72 to 85% in this subset. Reperfused patients in cardiogenic shock had almost halved in-hospital morality rates compared to patients without reperfusion therapy. Patients in cardiogenic shock in P-PCI subgroup had worsened outcomes compared to fi brinolysis subgroup evaluating mortality rate alone. However, rates of P-PCI especially in last years have increased. P-PCI was widely applied in critically ill, resuscitated cardiogenic shock patients, and even in those with serious accompanying diseases possibly regarded as contraindication for FL.
In-hospital mortality rates in STEMI patients undergoing P-PCI in respect to percent from treated patients increased over years. However Eastern Clinical University Hospital P-PCI policy for all--comers was initiated. Thus, critically ill patients as well as aging patients and patients with contraindications for other treatment options received P-PCI, which led to relatively higher in-hospital mortality rates in respect to percent from treated patients in this subset. Nonetheless, the total in-hospital mortality in STEMI patients (Tables 2 and 3) was decreasing over years, thus incremental benefi t of more aggressive reperfusion in combination with better use of drug therapy could serve as explanation. A higher proportion of STEMI patients were hospitalized in cardiogenic shock (8.6% in 2005 versus 10.2% in 2010) and higher proportion of patients in age group above 80 years (15.7% in 2005 vs. 18.4% in 2010 from all ACS patients), subgroup of patients with worsened prognosis. This registry is limited only with in-hospital data, which in terms of mortality is not the best refl ection of quality of care, while guidelines based management, P-PCI in STEMI and early interventional strategy in NSTE-ACS are believed to reduce serious adverse cardiac events including mortality in longer term [6, 7, [10] [11] [12] [13] [14] .
In NSTE-ACS patients intra-hospital death rate decreased in 2010 compared with 2006-2009, possibly refl ecting better adherence to guidelines recommended therapy and intensifi ed patient transfer from community hospitals to interventional centers.
Emergency care specialists, cardiologists, and general practitioners are being continuously educated; however, acceptable reperfusion rates in STEMI patients were not achieved. Insuffi cient amount of trained and experienced interventional cardiologists outside capital city is the main barrier for wider P-PCI implementation across the country. Until now some physicians and EMS specialists have conservative attitude towards early interventional strategy in STEMI as well as in NSTE-ACS. Thus, the development of ACS teams at community hospitals able to identify STEMI patients accurately as well as high and immediate risk NSTE-ACS eligible for P-PCI or early interventional treatment, correctly administer preferred initial medications, and rapidly transfer patients directly to the specialized center is still needed.
Conclusions
Annual incidence of ACS, especially NSTE-ACS as assessed by acute coronary syndrome registry decreased over years. Better adherence to guidelines recommended therapy and more often use of interventional strategy in analyzed time period from year to year was observed. A nationwide P-PCI strategy for STEMI was introduced in the previous years and subsequently the rate of P-PCI increased seven-fold since 2005. Nevertheless, still signifi cant number of STEMI patients did not receive any reperfusion therapy resulting in high mortality rates in this subgroup. In NSTE-ACS intra-hospital death rate decreased and early interventional strategy increased from year to year in analyzed time period.
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